CATCH THE BUZZ
Véto-pharma Names Phillip Craft as Apivar's® U.S. Technical Advisor
New York, NY –April 2, 2013 –Véto-pharma S.A., the French veterinary
pharmaceutical company specializing in honey bee health, announced today
that Phillip Craft, former state apiarist for the Kentucky Department of
Agriculture, has been named to the new position of U.S. technical advisor for
Véto-pharma's Apivar® honeybee miticide product line.
“Phil has worked with beekeepers, beekeepers' organizations, apiculture
extension specialists and scientists for more than a decade, and is very familiar
with the needs of commercial and hobbyist beekeepers," says José Nobre,
Véto-pharma's president and chief executive officer. "With his strong track
record as an educator and communicator, Phil will be an excellent liaison
between Véto-pharma and its U.S. customer base, working with our distributors
and beekeeper associations to foster healthy apiaries nation-wide."
Craft served as Kentucky's state apiarist from 1999 through 2011. He is a past
president and past chairman of the Heartland Apicultural Society, past program
chairman of the Eastern Apicultural Society, and past president of the Apiary
Inspectors of America. He earned a Bachelor's degree in biology from Oberlin
College in Ohio, and a Bachelor's degree in civil engineering from the
University of Kentucky.
During his tenure as state apiarist, Craft helped establish a network of six
beekeeping schools and expand the number of local beekeeper associations in
Kentucky from 15 in 1999 to more than 40 in 2011. He created a web site,
www.philcrafthivecraft.com, and an email newsletter that have attracted a large
audience of beekeepers across the U.S. He writes a monthly education column
for Bee Culture magazine, and is a popular speaker at beekeeping events
across the country.
“Phil’s broad beekeeping knowledge, proven communications skills, and
success in helping apiarists advance the science of beekeeping will be a
tremendous asset to our expansion in North America,”Nobre added. "We are
very pleased that Phil will represent Véto-pharma's interests in the U.S. and
help uphold our commitment to apiarists and honey bee health."
Apivar is a miticide used to treat honey bee colonies for Varroa mites, one of
the leading causes of global honey bee population decline and a contributing
factor in Colony Collapse Disorder (CCD). Apivar kills up to 99 percent of
Varroa mites in one application; it has proven safe and effective for more than
15 years; it leaves no significant residues in hive products; and, it is convenient
and easy to use. The U. S. Environmental Protection Agency granted Section 3
registration approval to Apivar on March 11, 2013.
"I have been a beekeeper for almost 20 years and enjoy interacting with fellow
beekeepers," Craft said. "With the increasing challenges beekeepers face
today, I think we owe it to the bees— and to ourselves— to use every tool
available to keep honey bee colonies healthy. Apivar is an excellent solution to
a serious problem, so I'm very pleased to help people use it to its very best
Véto-pharma S.A. is a veterinary pharmaceutical company that develops and
markets innovative products to help commercial and hobbyist beekeepers
prevent and control hive diseases and improve honey bee health. Véto-pharma's
products are sold to beekeepers through distributors in North America, Europe
and Asia. Headquartered in Paris, the Company's U.S. operations are based in
New York, NY. Visit www.apivar.net for more information.